Chitosan-assisted immobilization of serratiopeptidase on magnetic nanoparticles, characterization and its target delivery

Journal of Drug Targeting

Volumn 22, Issue 2, 2014, Pages 123-137

  Kumar, Sandeep ^a   Jana, Asim K ^a   Dhamija, Isha ^b   Maiti, Mithu ^a  

^a DR B R AMBEDKAR NATIONAL INSTITUTE OF TECHNOLOGY   (India)

^b GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Carrageenan induced paw oedema; Characterizations; Immobilization; Magnetic nanoparticles; Serratiopeptidase; Target delivery

Indexed keywords

CARRAGEENAN; CHITOSAN; GLUTARALDEHYDE; IMMOBILIZED ENZYME; MAGNETIC NANOPARTICLE; SERRATIOPEPTIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CRYSTAL STRUCTURE; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; ENZYME IMMOBILIZATION; ENZYME KINETICS; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; SURFACE CHARGE; SURFACE PROPERTY; THERMOGRAVIMETRY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CHITOSAN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; IMMOBILIZATION; INFLAMMATION; MAGNETITE NANOPARTICLES; MALE; PARTICLE SIZE; PEPTIDE HYDROLASES; RATS; RATS, WISTAR;

EID: 84891788399     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2013.844157     Document Type: Article

References (63)

1. Joshi KK, Nerurkar RP. Anti-inflammatory effect of the serratiopeptidase-rationale or fashionable: a study in rat paw oedema model induced by the carrageenan. Indian J Physiol Pharmacol 2012;56:367-74.
2. Panagariya A, Sharma A. A preliminary trial of serratiopeptidase in patients with carpal tunnel syndrome. J Assoc Physicians India 1999;47:1170-2.
3. Kee W, Tan S, Lee V, Salmon Y. The treatment of breast engorgement with serrapeptase (Danzen): a randomised doubleblind controlled trial. Singapore Med J 1989;30:48-54.
4. Nakamura S, Hashimoto Y, Mikami M, et al. Effect of the proteolytic enzyme serrapeptase in patients with chronic airway disease. Respirology 2003;8:316-20.
5. Al-Khateeb TH, Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. Int J Oral Maxillofac Surg 2008;37: 264-8.
6. Rath G, Johal ES, Goyal AK. Development of serratiopeptidase and metronidazole based alginate microspheres for wound healing. Artif Cells Blood Substit Immobil Biotechnol 2011;39:44-50.
7. Sandhya KV, Devi GS, Mathew ST. Liposomal formulations of serratiopeptidase: in vitro studies using PAMPA and caco-2 models. Mol Pharm 2007;5:92-7.
8. Mazzone A, Catalan M, Costanzo M. Evaluation of serratiopeptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double blind, randomized trial versus placebo. J Int Med Res 1990;18:379-88.
9. Mahato RI, Narang AS, Thoma L, Miller DD. Emerging trends in oral delivery of peptide and protein drugs. Crit Rev Ther Drug Carrier Syst 2003;20:153-214.
10. Nirale N, Menon M. Topical formulations of serratiopeptidase: development and pharmacodynamic evaluation. Indian J Pharm Sci 2010;72:65-71.
11. Schellmann N, Deckert PM, Bachran D, et al. Targeted enzyme prodrug therapies. Mini-Rev Med Chem 2010;10:887-904.
12. Appel E, Rabinkov A, Neeman M, et al. Conjugates of daidzeinalliinase as a targeted pro-drug enzyme system against ovarian carcinoma. J Drug Target 2011;19:326-35.
13. Heidari Majd M, Asgari D, Barar J, et al. Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles. J Drug Target 2013;21:328-40.
14. Kumar A, Zhang X, Liang X-J. Gold nanoparticles: emerging paradigm for targeted drug delivery system. Biotechnol Adv 2013;31:593-606.
15. Singh R, Lillard Jr JW, Nanoparticle-based targeted drug delivery. Exp Mol Pathol 2009;86:215-23.
16. Krukemeyer MG, Krenn V, Jakobs M, Wagner W. Magnetic drug targeting in a rhabdomyosarcoma rat model using magnetitedextran composite nanoparticle-bound mitoxantrone and 0.6 tesla extracorporeal magnets sarcoma treatment in progress. J Drug Target 2012;20:185-93.
17. Kumar S, Mohan U, Kamble AL, et al. Cross-linked enzyme aggregates of recombinant Pseudomonas putida nitrilase for enantioselective nitrile hydrolysis. Bioresour Technol 2010;101: 6856-8.
18. Verma M, Barrow C, Puri M. Nanobiotechnology as a novel paradigm for enzyme immobilisation and stabilisation with potential applications in biodiesel production. Appl Microbiol Biotechnol 2013;97:23-39.
19. Chen J-P, Yang P-C, Ma Y-H, et al. Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle. Int J Nanomedicine 2012;7:5137-49.
20. Chen JP, Yang PC, Ma YH. Characterization of chitosan magnetic nanoparticles for in situ delivery of tissue plasminogen activator. Carbohydr Polym 2011;84:364-72.
21. Bi F, Zhang J, Su Y, et al. Chemical conjugation of urokinase to magnetic nanoparticles for targeted thrombolysis. Biomaterials 2009;30:5125-30.
22. Ren L, Wang X, Wu H, et al. Conjugation of nattokinase and lumbrukinase with magnetic nanoparticles for the assay of their thrombolytic activities. J Mol Catal B Enzym 2010;62:190-6.
23. Kalkan NA, Aksoy S, Aksoy EA, et al. Preparation of chitosancoated magnetite nanoparticles and application for immobilization of laccase. J Appl Polym Sci 2011;123:707-16.
24. Kumar R, Inbaraj BS, Chen BH. Surface modification of superparamagnetic iron nanoparticles with calcium salt of poly(g-glutamic acid) as coating material. Mater Res Bull 2010; 45:1603-7.
25. Liang Y-Y, Zhang L-M, Li W, et al. Polysaccharide-modified iron oxide nanoparticles as an effective magnetic affinity adsorbent for bovine serum albumin. Colloid Polym Sci 2007; 285:1193-9.
26. Petri-Fink A, Steitz B, Finka A, et al. Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies. Eur J Pharm Biopharm 2008;68:129-37.
27. Zhuo Y, Yuan P-X, Yuan R, et al. Bienzyme functionalized threelayer composite magnetic nanoparticles for electrochemical immunosensors. Biomaterials 2009;30:2284-90.
28. Tang T, Fan H, Ai S, et al. Hemoglobin (Hb) immobilized on amino-modified magnetic nanoparticles for the catalytic removal of bisphenol A. Chemosphere 2011;83:255-64.
29. Jiang Y, Guo C, Xia H, et al. Magnetic nanoparticles supported ionic liquids for lipase immobilization: enzyme activity in catalyzing esterification. J Mol Catal B Enzym 2009;58:103-9.
30. Ziv-Polat O, Topaz M, Brosh T, et al. Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles. Biomaterials 2010;31:741-7.
31. Yu C-C, Kuo Y-Y, Liang C-F, et al. Site-specific immobilization of enzymes on magnetic nanoparticles and their use in organic synthesis. Bioconjug Chem 2012;13:714-24.
32. Namdeo M, Bajpai SK. Immobilization of a-amylase onto cellulose-coated magnetite (CCM) nanoparticles and preliminary starch degradation study. J Mol Catal B Enzym 2009;59: 134-9.
33. Bhattarai S, Kc R, Kim S, et al. N-hexanoyl chitosan stabilized magnetic nanoparticles: implication for cellular labeling and magnetic resonance imaging. J Nanobiotechnol 2008;6. Available from: http://www.jnanobiotechnology.com/ content/6/1/1 [last accessed 2 Oct 2013].
34. Wu Y, Wang Y, Luo G, et al. In situ preparation of magnetic Fe3O4-chitosan nanoparticles for lipase immobilization by cross-linking and oxidation in aqueous solution. Bioresour Technol 2009;100: 3459-64.
35. Institute of Health, National Academy of Science. Food chemical codex. 5th ed. Washington, DC: Institute of Health, National Academy of Science; 2001: 923-4.
36. Li G-y, Jiang Y-r, Huang K-l, et al. Preparation and properties of magnetic Fe3O4-chitosan nanoparticles. J Alloys Comp 2008;466: 451-6.
37. Dandamudi S, Campbell RB. The drug loading, cytotoxicty and tumor vascular targeting characteristics of magnetite in magnetic drug targeting. Biomaterials 2007;28:4673-83.
38. Rauf S, Ihsan A, Akhtar K, et al. Glucose oxidase immobilization on a novel cellulose acetate-polymethylmethacrylate membrane. J Biotechnol 2006;121:351-60.
39. Bosman IJ, Ensing K, de Zeeuw RA. Standardization procedure for the in vitro skin permeation of anticholinergics. Int J Pharm 1998; 169:65-73.
40. Lopez RFV, Collett JH, Bentley MVLB. Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone. Int J Pharm 2000;200:127-32.
41. Peppas N. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 1985;60:110-11.
42. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Delivery Rev 2001;48:139-57.
43. Huang G-J, Pan C-H, Liu F-C, et al. Anti-inflammatory effects of ethanolic extract of Antrodia salmonea in the lipopolysaccharide-stimulated RAW246.7 macrophages and the-carrageenan-induced paw edema model. Food Chem Toxicol 2012; 50:1485-93.
44. Sadeghi H, Hajhashemi V, Minaiyan M, et al. A study on the mechanisms involving the anti-inflammatory effect of amitriptyline in carrageenan-induced paw edema in rats. Eur J Pharmacol 2011; 667:396-401.
45. Zhu A, Yuan L, Liao T. Suspension of Fe3O4 nanoparticles stabilized by chitosan and o-carboxymethylchitosan. Int J Pharm 2008;350:361-8.
46. Kouassi GK, Irudayaraj J, McCarty G. Examination of cholesterol oxidase attachment to magnetic nanoparticles. J Nanobiotechnol 2005;3. Available from: http://www.jnanobiotechnology.com/content/3/1/1 [last accessed 2 Oct 2013].
47. Chaleawlert-umpon S, Pimpha N. Morphology study of superparamagnetic iron oxide-chitosan nanoparticles. J Microsc Soc Thialand 2009;23:62-5.
48. Cao H, He J, Deng L, Gao X. Fabrication of cyclodextrinfunctionalized superparamagnetic Fe3O4/amino-silane core-shell nanoparticles via layer-by-layer method. Appl Surf Sci 2009;255: 7974-80.
49. Yamaura M, Camilo RL, Sampaio LC, et al. Preparation and characterization of (3-aminopropyl)triethoxysilane-coated magnetite nanoparticles. J Magn Magn Mater 2004;279:210-17.
50. Faraji M, Yamini Y, Rezaee M. Magnetic nanoparticles: synthesis, stabilization, functionalization, characterization and applications. J Iran Chem Soc 2010;7:1-37.
51. Talbert JN, Hotchkiss JH. Chemical modification of lactase for immobilization on carboxylic acid-functionalized microspheres. Biocatal Biotransformation 2012;30:446-54.
52. Hsieh H-J, Liu P-C, Liao W-J. Immobilization of invertase via carbohydrate moiety on chitosan to enhance its thermal stability. Biotechnol Lett 2000;22:1459-64.
53. Hu B, Pan J, Yu H-L, et al. Immobilization of Serratia marcescens lipase onto amino-functionalized magnetic nanoparticles for repeated use in enzymatic synthesis of Diltiazem intermediate. Process Biochem 2009;44:1019-24.
54. Zhu J, Sun G. Lipase immobilization on glutaraldehyde-activated nanofibrous membranes for improved enzyme stabilities and activities. React Funct Polym 2012;72:839-45.
55. Zhu H, Pan J, Hu B, et al. Immobilization of glycolate oxidase from Medicago falcata on magnetic nanoparticles for application in biosynthesis of glyoxylic acid. J Mol Catal B Enzym 2009;61: 174-9.
56. Liu Y, Jia S, Wu Q, et al. Studies of Fe3O4-chitosan nanoparticles prepared by co-precipitation under the magnetic field for lipase immobilization. Catal Commun 2011;12:717-20.
57. Xu H, Song T, Bao X, et al. Site-directed research of magnetic nanoparticles in magnetic drug targeting. J Magn Magn Mater 2005;293:514-9.
58. Vichasilp C, Nakagawa K, Sookwong P, et al. A novel gelatin crosslinking method retards release of mulberry 1-deoxynojirimycin providing a prolonged hypoglycaemic effect. Food Chem 2012;134:1823-30.
59. Marroquin-Segura R, Flores-Pimentel M, Carreon-Sanchez R, et al. The effect of the aqueous extract of Helietta parvifolia A. Gray (Rutaceae) stem bark on carrageenan-induced paw oedema and granuloma tissue formation in mice. J Ethnopharmacol 2009;124: 639-41.
60. Swami G, Pooja D, Kulhari H, et al. Surface modification of poly (l-lactic acid) microspheres for site-specific delivery of ketoprofen for chronic inflammatory disease. J Drug Target 2013; 21:232-9.
61. Vinegar R, Schreiber W, Hugo R. Biphasic development of carrageenan edema in rats. J Pharmacol Exp Ther 1969;166:96-103.
62. Maheshwari M, Miglani G, Mali A, et al. Development of tetracycline-serratiopeptidase-containing periodontal gel: formulation and preliminary clinical study. AAPS PharmSciTech 2006;7: E162-71.
63. Chertok B, David AE, Yang VC. Brain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topography. J Control Release 2011;155: 393-9.